Speaker Details

DISCLOSURES

AbbVie – Consultant (1099 relationship)(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); Attovia Therapeutics – Investigator(Fees); Bristol Myers Squibb – Consultant (1099 relationship)(Honoraria); Edesa Biotech – Stockholder Public Company(Stock); Equillium, Inc. – Stockholder Public Company(Stock); Galderma – Consultant (1099 relationship)(Honoraria); HCW Biologics – Stockholder Public Company(Stock); Incyte – Consultant (1099 relationship)(Honoraria); Johnson and Johnson – Consultant (1099 relationship)(Honoraria); Kymera Therapeutics – Other(Stock Options); Leo Pharma – Consultant (1099 relationship)(Honoraria), Investigator(Fees); Navigator Medicines – Consultant (1099 relationship)(Honoraria); Nektar Therapeutics – Stockholder Public Company(Stock); Novartis – Consultant (1099 relationship)(Honoraria); Primus Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Priovant Therapeutics – Investigator(Fees); Q32 Bio Inc. – Other(Stock); Sanofi – Consultant (1099 relationship)(Honoraria), Investigator(Fees); Scinai Immunotherapeutics – Stockholder Public Company(Stock); Stifel Financial – Consultant (1099 relationship)(Honoraria); UCB – Consultant (1099 relationship)(Honoraria); Zura Bio – Stockholder Public Company(Stock);